The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 704.00
Bid: 703.00
Ask: 706.00
Change: 8.00 (1.15%)
Spread: 3.00 (0.427%)
Open: 686.00
High: 707.00
Low: 686.00
Prev. Close: 696.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 May 2017 07:00

RNS Number : 3446F
Bodycote PLC
17 May 2017
 

 

17 May 2017

Bodycote plc

Trading Update

 

Bodycote is issuing a trading update covering the period from 1 January to 30 April 2017 ("the period"), ahead of the Company's 64th Annual General Meeting, which will be held at 12.00pm today.

 

Current trading

Group revenue for the four months ended 30 April 2017 was £227.0m, 18.0% higher than the same period last year, 7.1% higher at constant exchange rates. Like-for-like revenues were higher by 3.9%. Aerospace, Defence & Energy business revenues were higher by 10.8% (0.6% at constant exchange rates). Automotive & General Industrial business revenues increased by 23.2% (11.8% at constant exchange rates).

 

The following review of the Group's markets quotes all movements on a like-for-like basis and at constant exchange rates:

 

Civil aviation revenues were higher by 3.8% year-on-year, as we continued to witness good growth in Western Europe. However, weak revenues from the defence sector and lower revenues from the Oil and Gas sector (where sales were still declining in the comparative period in 2016) substantially offset this growth.

 

Car and light truck revenues increased by 7.9%, with strong growth in Europe and our Emerging Markets. Meanwhile Heavy Truck and Bus revenues have yet to rebound and showed a small decrease in revenues in the period. General industrial revenues were 7.6% higher, the first positive growth we have seen in this segment for nearly three years. This recovery is predominantly being experienced in Europe, with limited North American growth so far.

 

Financial position

Net cash as at 30 April 2017 was £10.6m, compared to net cash of £1.1m at 31 December 2016 and represents a relatively strong cash flow for the period, as we controlled costs and managed working capital flows well. The 2016 final dividend of 10.8p per share will be paid on 2 June 2017, at a total cost of £20.5m.

 

Summary and Outlook

Bodycote's performance in the first four months of the year has been robust and in line with the Board's expectations. Accordingly, the Group's outlook for the year as a whole remains unchanged.

 

Trading update conference call

Stephen Harris and Dominique Yates will be hosting a conference call for analysts and investors at 8.00am BST today (17 May 2017).

Participant's dial in number: Toll - +44 0203 4270662

Toll free - 08082370060

Participants will be asked for names only, no PIN required

 

For further information, please contact:

 

Bodycote plc

Stephen Harris, Group Chief Executive

Dominique Yates, Chief Financial Officer

Tel No +44 (0) 1625 505300

 

FTI Consulting

Richard Mountain

Susanne Yule

Tel No +44 (0) 20 3727 1340

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDUDDBBGRL
Date   Source Headline
30th Nov 20234:30 pmPRNTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
10th Nov 202312:08 pmPRNDirector/PDMR Shareholding
9th Nov 20237:00 amRNSDirector Declaration
31st Oct 20234:30 pmPRNTotal Voting Rights
31st Oct 202310:07 amPRNDirector/PDMR Shareholding
18th Oct 20237:00 amRNSGroup Chief Executive Appointment
9th Oct 20237:00 amRNSSpecialist Tech Acquisitions & New HIP Facility
29th Sep 20234:30 pmPRNBodycote plc - Total Voting Rights
31st Aug 20234:30 pmPRNBodycote plc - Total Voting Rights
16th Aug 20232:38 pmPRNDirector/PDMR Shareholding
4th Aug 202310:43 amPRNHolding(s) in Company
31st Jul 20235:00 pmPRNTotal Voting Rights
27th Jul 20237:00 amRNSInterim results for the six months to 30 June 2023
30th Jun 20235:00 pmPRNTotal Voting Rights
31st May 202312:45 pmRNSSenior Independent Director succession
31st May 202312:43 pmRNSResult of AGM
31st May 20237:00 amRNSGroup Chief Executive Succession Process
31st May 20237:00 amRNSTrading Update
28th Apr 20235:02 pmPRNTotal Voting Rights
17th Mar 20237:00 amRNSFull year results for year ended 31 December 2022
16th Mar 20237:00 amRNSRemuneration Committee Chair Succession
18th Nov 20227:00 amRNSTrading Update
31st Oct 20227:00 amRNSAppointment of Chief Financial Officer
29th Jul 20227:00 amRNSInterim results for the six months to 30 June 2022
28th Jun 20229:22 amRNSHolding(s) in Company
31st May 20225:02 pmPRNTotal Voting Rights
27th May 20224:47 pmRNSHolding(s) in Company
27th May 20227:00 amRNSHolding(s) in Company
26th May 20225:11 pmRNSHolding(s) in Company
25th May 20222:41 pmPRNDirector/PDMR Shareholding
25th May 202212:21 pmRNSResult of AGM
25th May 20227:11 amRNSAudit Committee Chair Succession
25th May 20227:00 amRNSTrading Update
13th Apr 202211:00 amPRNHolding(s) in Company
6th Apr 20229:07 amPRNDirector/PDMR Shareholding
4th Apr 20224:16 pmPRNFinal Dividend Payment Date
31st Mar 20225:02 pmPRNTotal Voting Rights
28th Mar 202212:13 pmPRNDirector/PDMR Shareholding
25th Mar 20223:18 pmPRNDirector/PDMR Shareholding
25th Mar 20221:39 pmPRNAnnual Financial Report
25th Mar 20221:12 pmPRNDirector/PDMR Shareholding
15th Mar 20224:53 pmPRNDirector/PDMR Shareholding
14th Mar 20227:00 amRNSFull year results for year ended 31 December 2021
11th Mar 20227:00 amRNSAppointment of Non-Executive Director
8th Mar 20227:46 amPRNHolding(s) in Company
28th Feb 20225:01 pmPRNTotal Voting Rights
7th Feb 20227:00 amRNSDirectorate Change
4th Feb 20228:51 amPRNHolding(s) in Company
4th Feb 20228:48 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.